Showing results (351-360 of 832) with videos related to
Sort By:
Pageof 84
Diabetes Research and Clinical Practice|June 11, 2022
Association between plasma apolipoprotein M and cardiac autonomic neuropathy in type 1 diabetesMostafa Safi, Anna Borup, Christian Stevns Hansen, et al.Proteomics. Clinical Applications|December 8, 2010
The urinary proteome in diabetes and diabetes-associated complications: New ways to assess disease progression and evaluate therapyKasper Rossing, Harald Mischak, Peter Rossing, et al.Current Pharmaceutical Design|June 24, 2017
Trimethylamine N-oxide (TMAO) as a New Potential Therapeutic Target for Insulin Resistance and CancerJens Oellgaard, Signe Abitz Winther, Tobias Schmidt Hansen, et al.Journal of Diabetes and Its Complications|August 13, 2023
Risk of atrial fibrillation in individuals with dysglycemia and diabetesRasmus Rørth, Margit Kriegbaum, Mia Klinten Grand, et al.Journal of Translational Medicine|August 22, 2025
In silico prediction of optimal multifactorial intervention in chronic kidney diseaseAgnieszka Latosinska, Ioanna K Mina, Thi Minh Nghia Nguyen, et al.Qualitative Health Research|January 6, 2024
"I Haven't Told Anyone but You": Experiences and Biopsychosocial Support Needs of People With Type 2 Diabetes and Binge EatingPil Lindgreen, Ingrid Willaing, Loa Clausen, et al.Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 19, 2021
Medical therapies for prevention of cardiovascular and renal events in patients with atrial fibrillation and diabetes mellitusLaurent Fauchier, Giuseppe Boriani, Joris R de Groot, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 19, 2024
Summary of Research: Cardiovascular and Kidney Outcomes with Finerenone in Patients with Type 2 Diabetes and Chronic Kidney Disease-The FIDELITY Pooled AnalysisKarin Humle, Boris Klanger, Peter Kolkhof, et al.Diabetes Care|September 5, 2020
Improved Time in Range Over 1 Year Is Associated With Reduced Albuminuria in Individuals With Sensor-Augmented Insulin Pump-Treated Type 1 DiabetesAjenthen G Ranjan, Signe V Rosenlund, Tine W Hansen, et al.Diabetes, Obesity & Metabolism|February 10, 2025
Efficacy and hypoglycaemia outcomes with once-weekly insulin icodec versus once-daily basal insulin in individuals with type 2 diabetes by kidney function: A post hoc participant-level analysis of the ONWARDS 1-5 trialsPeter Rossing, Malik Benamar, Alice Y Y Cheng, et al.Pageof 84